A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
Crossref DOI link: https://doi.org/10.1186/s13045-016-0379-6
Published Online: 2017-01-03
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Erhao
Xu, Hanmei
Funding for this research was provided by:
Ministry of Science and Technology of the People's Republic of China (No. SKLNMBZ201403, No. 2012ZX09103301-004, No. 2014ZX09508007)